CVS: committed to safe medication disposal
CVS Health today underscored its commitment to helping communities safely dispose of unwanted medications, particularly as an important step in helping to address and prevent opioid abuse and misuse.
Pharmacy
Aurobindo receives FDA approval for capecitabine tablets
Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for capecitabine tablets USP, 150 mg, and 500 mg. Aurobindo’s capecitabine tablets USP are an AB-rated generic equivalent to the reference listed drug Xeloda.
CVS to acquire Red Cross Pharmacy
Red Cross Pharmacy, a top 50 drugstore chain as well as one of the oldest pharmacy businesses in the country, announced that it plans to sell its 14 retail pharmacies to CVS Pharmacy effective June 6, 2018. The Company, which primarily services markets in northwest central Missouri, has two
NCPA workshop fosters pharmacy ownership
ALEXANDRIA, Va. – Ask pharmacist Hashim Zaibak how he came to own 11 pharmacies (all under the Hayat Pharmacy umbrella) in Milwaukee, and he’ll tell you about a workshop he attended several years ago, conducted by the National Community Pharmacists Association.
Mylan adds to growing women’s healthcare portfolio
Global pharmaceutical company Mylan N.V. announced the U.S. launch of Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg, a generic version of Bayer’s Yaz tablets. Mylan Pharmaceuticals received final approval from the U.S.
New study looks at how Americans are taking medications for chronic conditions
According to a new survey, Knowing But Not Doing: The State of Rx Adherence in America Report from Express Scripts, many Americans on medications for chronic diseases are not concerned about missing doses, resent their spouses/partners reminding them to take their medicine and think they do a better
CVS releases 11th annual CSR Report
CVS Health today released its 11th annual Corporate Social Responsibility (CSR) Report, detailing its latest efforts to shape the future of health care, reduce environmental impact and exemplify corporate leadership in fulfilling the company’s purpose of helping people on their path to better healt
Walgreens medication disposal program nets over 270 tons of unused meds
Walgreens has reported that its safe medication disposal program has collected and safely disposed of more than 270 tons of medications, or the equivalent of about 150 cars, since the launch of the program in 2016.
Avella to improve access to Naloxone
Avella has announced it will distribute naloxone, a powerful therapy used to treat opioid overdoses, as part of an innovative new program designed to improve access to the drug.
Genoa Healthcare moves to Renton headquarters
Genoa Healthcare announced it has moved its corporate headquarters from Tukwila, Wash. to Triton Towers Three, located at 707 South Grady Way, in Renton, Wash.
Panzer hails mentorship and collaboration
In his first remarks as chairman of the National Association of Chain Drug Stores, Mark Panzer thanked those who have taught and collaborated with him throughout his 46-year retail career.
NACDS Foundation announces scholarships, grants
PALM BEACH, Fla. –The NACDS Foundation has distributed $220,000 in scholarships and grants as part of an ongoing commitment to advancing patient care through pharmacy education as part of the 23rd Annual NACDS Foundation Scholarship Program.
Panzer vows to keep NACDS focused on patients’ needs
Mark Panzer, chairman of the National Association of Chain Drug Stores, has been involved with the chain drug business for over 40 years.
FDA recommends the approval of Baricitinib 2mg
Eli Lilly and Incyte Corp. announced that the U.S.
Kroger and Cardinal Health to co-host drug take-back events
Kroger Co. and Cardinal Health announced the companies will host joint drug take-back events at more than 100 Kroger Family of Pharmacies locations from 10 a.m. to 2 p.m. local time on April 28, 2018 across America, as part of the U.S.
Lupin gets FDA approval for generic Xenazine tablets
Lupin announced today that it has received final approval for its Tetrabenazine tablets, 12.5 mg and 25 mg from the United States Food and Drug Administration (FDA) to market a generic version of Valeant Pharmaceuticals North America’s Xenazine tablets, 12.5 mg and 25 mg.